All PlansAdministrativeMedium impact
Recall: Insulin Glargine
UPMC Health Plan·Endocrinology, Family Medicine, Internal Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Mylan Pharmaceuticals has recalled one batch of Insulin Glargine (insulin glargine-yfgn) injection 100 units/mL 3mL prefilled pens. This is a drug safety recall that may affect patient care and prescription fulfillment.
Action Required
Immediately: Clinical staff should identify patients using the recalled batch of Insulin Glargine prefilled pens and coordinate with prescribing providers for alternative insulin products. Pharmacy team should check inventory for recalled batch and remove from dispensing. Review full recall text at source URL for specific lot numbers and patient safety instructions.